Verastem (VSTM) Cash from Financing Activities (2011 - 2026)
Verastem's quarterly Cash from Financing Activities came in at $28.7 million in Q1 2026, down 57.45% year-on-year from $67.4 million in Q1 2025, and down 70.9% quarter-over-quarter from $98.6 million in Q4 2025.
Verastem has reported Cash from Financing Activities for 16 years, with the latest figure at $28.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 57.45% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $224.6 million (up 85.04% YoY), and the FY2025 full-year result was $263.3 million, up 380.64% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $28.7 million, down from $98.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $98.6 million in Q4 2025, with the low at -$891000.0 in Q3 2023.
- Average Cash from Financing Activities over 5 years is $33.3 million, with a median of $25.5 million recorded in 2022.
- Year-over-year, Cash from Financing Activities slumped 103.48% in 2023 and jumped 19708.89% in 2025.
- Tracing VSTM's Cash from Financing Activities over 5 years: stood at $25.6 million in 2022, then tumbled by 101.74% to -$446000.0 in 2023, then soared by 266.37% to $742000.0 in 2024, then jumped by 13186.12% to $98.6 million in 2025, then sank by 70.9% to $28.7 million in 2026.
- The last three Cash from Financing Activities figures came in at $28.7 million (Q1 2026), $98.6 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 28.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.69 Mn |
| Mar 31, 2026 | 28.69 Mn |
| Dec 31, 2025 | 98.58 Mn |
| Dec 31, 2025 | 98.58 Mn |
| Sep 30, 2025 | 17.88 Mn |
| Sep 30, 2025 | 17.88 Mn |
| Jun 30, 2025 | 79.42 Mn |
| Jun 30, 2025 | 79.42 Mn |
| Mar 31, 2025 | 67.43 Mn |
| Mar 31, 2025 | 67.43 Mn |
| Dec 31, 2024 | 742,000.00 |
| Dec 31, 2024 | 742,000.00 |
| Sep 30, 2024 | 53.60 Mn |
| Sep 30, 2024 | 53.60 Mn |
| Jun 30, 2024 | -405,000.00 |
| Jun 30, 2024 | -405,000.00 |
| Mar 31, 2024 | 846,000.00 |
| Mar 31, 2024 | 846,000.00 |
| Dec 31, 2023 | -446,000.00 |
| Dec 31, 2023 | -446,000.00 |
| Sep 30, 2023 | -891,000.00 |
| Sep 30, 2023 | -891,000.00 |
| Jun 30, 2023 | 91.48 Mn |
| Jun 30, 2023 | 91.48 Mn |
| Mar 31, 2023 | 44.05 Mn |
| Mar 31, 2023 | 44.05 Mn |
| Sep 30, 2022 | 25.62 Mn |
| Sep 30, 2022 | 25.62 Mn |
| Jun 30, 2022 | 708,000.00 |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 25.45 Mn |
| Mar 31, 2022 | 25.45 Mn |
| Dec 31, 2021 | 6.81 Mn |
| Dec 31, 2021 | 6.81 Mn |
| Sep 30, 2021 | 169,000.00 |
| Sep 30, 2021 | 169,000.00 |
| Jun 30, 2021 | 489,000.00 |
| Jun 30, 2021 | 489,000.00 |
| Mar 31, 2021 | -578,000.00 |
| Mar 31, 2021 | -578,000.00 |
| Dec 31, 2020 | -36.61 Mn |
| Dec 31, 2020 | -36.61 Mn |
| Sep 30, 2020 | 137,000.00 |
| Sep 30, 2020 | 137,000.00 |
| Jun 30, 2020 | 12.68 Mn |
| Jun 30, 2020 | 12.68 Mn |
| Mar 31, 2020 | 93.42 Mn |
| Mar 31, 2020 | 93.42 Mn |
| Dec 31, 2019 | -12.70 Mn |
| Dec 31, 2019 | -12.70 Mn |
| Sep 30, 2019 | 494,000.00 |
| Sep 30, 2019 | 494,000.00 |
| Jun 30, 2019 | 9.69 Mn |
| Jun 30, 2019 | 9.69 Mn |
| Mar 31, 2019 | 75,000.00 |
| Mar 31, 2019 | 75,000.00 |
| Dec 31, 2018 | 145.47 Mn |
| Dec 31, 2018 | 145.47 Mn |
| Sep 30, 2018 | 74,000.00 |
| Sep 30, 2018 | 74,000.00 |
| Jun 30, 2018 | 115.32 Mn |
| Jun 30, 2018 | 115.32 Mn |
| Mar 31, 2018 | 299,000.00 |
| Mar 31, 2018 | 299,000.00 |
| Dec 31, 2017 | 46.72 Mn |
| Dec 31, 2017 | 46.72 Mn |
| Sep 30, 2017 | 14.21 Mn |
| Sep 30, 2017 | 14.21 Mn |
| Jun 30, 2017 | -138,000.00 |
| Jun 30, 2017 | -138,000.00 |
| Mar 31, 2017 | 2.39 Mn |
| Mar 31, 2017 | 2.39 Mn |
| Mar 31, 2016 | -5,000.00 |
| Mar 31, 2016 | -5,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Jun 30, 2015 | 8.12 Mn |
| Jun 30, 2015 | 8.12 Mn |
| Mar 31, 2015 | 55.35 Mn |
| Mar 31, 2015 | 55.35 Mn |
| Dec 31, 2014 | 9.52 Mn |
| Dec 31, 2014 | 9.52 Mn |
| Sep 30, 2014 | -199,000.00 |
| Sep 30, 2014 | -199,000.00 |
| Jun 30, 2014 | -59,000.00 |
| Jun 30, 2014 | -59,000.00 |
| Mar 31, 2014 | -487,000.00 |
| Mar 31, 2014 | -487,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Dec 31, 2013 | 2,000.00 |
| Sep 30, 2013 | 59.29 Mn |
| Sep 30, 2013 | 59.29 Mn |
| Jun 30, 2013 | -34,000.00 |
| Jun 30, 2013 | -34,000.00 |
| Mar 31, 2013 | -765,000.00 |
| Mar 31, 2013 | -765,000.00 |
| Dec 31, 2012 | 1,000.00 |
| Dec 31, 2012 | 1,000.00 |
| Sep 30, 2012 | 2,000.00 |
| Sep 30, 2012 | 2,000.00 |
| Mar 31, 2012 | 57.60 Mn |
| Mar 31, 2012 | 57.60 Mn |
| Dec 31, 2011 | 19.49 Mn |
| Dec 31, 2011 | 19.49 Mn |
| Sep 30, 2011 | 31.90 Mn |
| Sep 30, 2011 | 31.90 Mn |
| Jun 30, 2011 | 12.07 Mn |
| Jun 30, 2011 | 12.07 Mn |